Work

Comparative evaluation of oral misoprostol and intramuscular oxytocin for active management of the third stage of labor: A prospective study

Year: 2026
Type: article
Study design: Clinical Trial
Abstract: Background : Postpartum hemorrhage (PPH) is a major cause of maternal morbidity and mortality, especially in low- and middle-income countries. Active management of the third stage of labor (AMTSL) significantly reduces PPH risk, with oxytocin as the first-line uterotonic. However, oxytocin’s reliance on cold-chain storage and skilled administration limits its use in low-resource settings. Misoprostol, being thermostable, easy to administer and suitable for peripheral use, has emerged as a potential alternative. This study compares the efficacy and safety of oral misoprostol (600 mcg) versus intramuscular oxytocin (10 IU) in a tertiary care setting. Materials and Methods : A prospective comparative study was conducted at Dr. D. Y. Patil Medical College Hospital, Pune, from September 2023 to January 2025, including 146 women undergoing vaginal delivery. Participants were randomized to receive either oral misoprostol (n=75) or intramuscular oxytocin (n=71) within one minute of delivery. Primary outcomes included the need for additional uterotonics, surgical interventions and blood transfusions. Secondary outcomes were total blood loss (Brass V drape), hemoglobin and hematocrit changes and adverse effects. Results : Maternal age and gestational age were comparable between groups. Additional uterotonics were needed more in the oxytocin group (19.7% vs. 10.7%, p=0.126). Surgical interventions like manual removal of placenta, exploration and repair of deep perineal and vaginal tears and uterine exploration with tamponade insertion were significantly higher in the oxytocin group (11.3% vs. 2.7%, p=0.040) which were needed for cases of refractory atonic PPH and retained placenta where medical management failed. Blood loss, hematological changes and side effects were similar across groups. Conclusion : Oral misoprostol is as effective as intramuscular oxytocin for AMTSL, with fewer surgical interventions and comparable safety. It is a practical alternative, particularly in low-resource settings.
Language: English
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7235666984
FWCI:
Cites: 15
Cited by:
Related to: 10